GM Warburg Commercial says ongoing central bank liquidity operations and huge $1.9tn US stimulus to support stock prices regardless of hit to global economic growth say GM Warburg Commercial analysts.
That�s the view expressed by analysts at Seoul-based investment house, GM Warburg Commercial in an investment note emailed to clients last week.
The firm says it fully expects stock values in key markets around the world to remain well-supported by record monetary stimulus from the US Federal Reserve, the European Central Bank and a number of others as they try to ensure that plenty of liquidity and credit is available to businesses, investors and consumers.
As is often the case with vast quantities of monetary stimulus, particularly quantitative easing, money flows to where it is mostly like to generate a return and right now, markets in the US, Europe and Asia are in a pretty bullish mood. Were seeing values surge in technology and energy shares, particularly oil, as the world gains confidence amid the rollout of various COVID-19 vaccines and the hope of an ongoing reflation trade, explained Harry Woods, Director of Private Clients at GM Warburg Commercial.
Now is not a time to be taking profits, he concluded.
The coronavirus pandemic has killed more than 2 million people around the world since it appeared in Wuhan, China in December 2019 and the response to the virus has seen economies around the world brought to a complete standstill as countries struggled to ease the burden on healthcare services.
Let’s block ads! (Why?)
HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…
HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…
JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…